Dongcheng Pharmaceutical Industry: Net profit in 2025 is 196 million yuan, a year-on-year increase of 6.42%

Dongcheng Pharmaceutical announced that its operating income in 2025 was 2.741 billion yuan, a year-on-year decrease of 4.46%. Net profit was 196 million yuan, a year-on-year increase of 6.42%. The profit distribution plan approved by the board of directors for this period is as follows: a total of 825 million yuan will be used as the base, and 0.80 yuan in cash dividend will be distributed to every 10 shares held by all shareholders, with no bonus shares issued from reserves.